한국간담췌외과학회지 (Annals of Hepato-Biliary-Pancreatic Surgery)

  • 제27권4호
  • /
  • Pages.329-341
  • /
  • 2023
  • /
  • 2508-5778(pISSN)
  • /
  • 2508-5859(eISSN)
한국간담췌외과학회 (The Korean Association of Hepato-Biliary-Pancreatic Surgery)
권호 표지
DOI QR코드

DOI QR Code

Vascular tumors of the liver: A brief review

  • Sujata Sarangi (Department of Pathology, Grant Govt. Medical College) ;
  • Balamurugan Thirunavukkarasu (Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences) ;
  • Sudeep Khera (Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences) ;
  • Selvakumar B (Department of Surgical Gastroenterology, All India Institute of Medical Sciences) ;
  • Taruna Yadav (Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences)
  • 투고 : 2023.03.30
  • 심사 : 2023.09.18
  • 발행 : 2023.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Vascular tumors of the liver are mesenchymal lesions from endothelial cells. They range from common benign lesions such as haemangioma, intermediate tumors like Kaposi sarcoma, and perivascular epithelioid cell tumor to malignant tumors such as hepatic epithelioid hemangioendothelioma and hepatic angiosarcoma in adults. Pediatric vascular tumors of the liver also include benign, locally aggressive, borderline, and malignant masses with haemangiomas being the most common benign tumors and epithelioid hemangioendothelioma being an uncommon pediatric malignancy. The list of these lesions is completed by nodular regenerative hyperplasia, solitary fibrous tumour, and hepatic small vessel neoplasms (HSVN). Some of these tumors are uncommon and rare. This review article aimed to enumerate hepatic vascular tumors along with their imaging, histopathology, molecular findings for accurate diagnosis that can result in better management.

키워드

참고문헌

  1. Lerut J, Iesari S. Vascular tumours of the liver: a particular story. Transl Gastroenterol Hepatol 2018;3:62. 
  2. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Vol 3. 5th ed. International Agency for Research on Cancer, 2020. 
  3. Bannoura S, Putra J. Primary malignant vascular tumors of the liver in children: angiosarcoma and epithelioid hemangioendothelioma. World J Gastrointest Oncol 2021;13:223-230.  https://doi.org/10.4251/wjgo.v13.i4.223
  4. Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014;60:1268-1289.  https://doi.org/10.1016/j.jhep.2014.01.021
  5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 2018;69:182-236.  https://doi.org/10.1016/j.jhep.2018.03.019
  6. Dasgupta R, Fishman SJ. ISSVA classification. Semin Pediatr Surg 2014;23:158161. 
  7. Choi BY, Nguyen MH. The diagnosis and management of benign hepatic tumours. J Clin Gastroenterol 2005;39:401-412.  https://doi.org/10.1097/01.mcg.0000159226.63037.a2
  8. Dokmak S, Ronot M. Chapter 88A - Benign liver lesions. In: Jarnagin W, ed. Blumgart's Surgery of the Liver, Biliary tract and Pancreas. 7th ed. Elsevier Inc., 2023:1181-1202. 
  9. Ehman EC, Torbenson MS, Wells ML, Welch BT, Thompson SM, Garg I, et al. Hepatic tumours of vascular origin: imaging appearances. Abdom Radiol (NY) 2018;43:1978-1990.  https://doi.org/10.1007/s00261-017-1401-3
  10. Ros PR, Erturk SM. Benign Tumours of the Liver. In: Gore RM, Levine MS, eds. Textbook of Gastrointestinal Radiology. 5th ed. Elsevier Inc., 2021:767-787. 
  11. Thampy R, Elsayes KM, Menias CO, Pickhardt PJ, Kang HC, Deshmukh SP, et al. Imaging features of rare mesenychmal liver tumours: beyond haemangiomas. Br J Radiol 2017;90:20170373. 
  12. Miyaki D, Aikata H, Waki K, Murakami E, Hashimoto Y, Nagaoki Y, et al. [Significant regression of a cavernous hepatic haemangioma to a sclerosed haemangioma over 12 years: a case study]. Nihon Shokakibyo Gakkai Zasshi 2011;108:954-961. Japanese. 
  13. Yoo BR, Han HY, Choi SY, Kim JH. Giant cavernous haemangioma coexistent with diffuse hepatic haemangiomatosis presenting as portal vein thrombosis and hepatic lobar atrophy. Ultrasonography 2014;33:65-70.  https://doi.org/10.14366/usg.13003
  14. Conter RL, Longmire WP Jr. Recurrent hepatic haemangiomas. Possible association with estrogen therapy. Ann Surg 1988;207:115-119.  https://doi.org/10.1097/00000658-198802000-00001
  15. Feurle GE. Arteriovenous shunting and cholestasis in hepatic haemangiomatosis associated with metoclopramide. Gastroenterology 1990;99:258-262.  https://doi.org/10.1016/0016-5085(90)91256-6
  16. Maeda E, Akahane M, Watadani T, Yoshioka N, Goto A, Sugawara Y, et al. Isolated hepatic haemangiomatosis in adults: report of two cases and review of the literature. Eur J Radiol Extra 2007;61:9-14.  https://doi.org/10.1016/j.ejrex.2006.10.007
  17. Chung EM, Lattin GE Jr, Cube R, Lewis RB, Marichal-Hernandez C, Shawhan R, et al. From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumours. Radiographics 2011;31:483-507.  https://doi.org/10.1148/rg.312105201
  18. Hsi Dickie B, Fishman SJ, Azizkhan RG. Hepatic vascular tumours. Semin Pediatr Surg 2014;23:168-172.  https://doi.org/10.1053/j.sempedsurg.2014.06.018
  19. Bisceglie AMD. Chapter 96 - Hepatic Tumours and Cysts. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Elsevier Inc., 2021:1509-1532. 
  20. Paradis V. Chapter 87 - Tumours of the liver: Pathologic aspects. In: Jarnagin W, ed. Blumgart's Surgery of the Liver, Biliary tract and Pancreas. 7th ed. Elsevier Inc., 2023:1152-1180. 
  21. Kristidis P, de Silva M, Howman-Giles R, Gaskin KJ. Infantile hepatic haemangioma: investigation and treatment. J Paediatr Child Health 1991;27:57-61.  https://doi.org/10.1111/j.1440-1754.1991.tb00348.x
  22. Mo JQ, Dimashkieh HH, Bove KE. GLUT1 endothelial reactivity distinguishes hepatic infantile haemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004;35:200-209.  https://doi.org/10.1016/j.humpath.2003.09.017
  23. Shastri S, Dubinsky MC, Fred Poordad F, Vasiliauskas EA, Geller SA. Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy. Arch Pathol Lab Med 2004;128:49-53.  https://doi.org/10.5858/2004-128-49-ENHOTL
  24. WHO Classification of Tumours Editorial Board. Digestive system tumours. 5th ed.International Agency for Research on Cancer, 2019. 
  25. Restrepo CS, Martinez S, Lemos JA, Carrillo JA, Lemos DF, Ojeda P, et al. Imaging manifestations of Kaposi sarcoma. Radiographics 2006;26:1169-1185.  https://doi.org/10.1148/rg.264055129
  26. Addula D, Das CJ, Kundra V. Imaging of Kaposi sarcoma. Abdom Radiol (NY) 2021;46:5297-5306.  https://doi.org/10.1007/s00261-021-03205-6
  27. Nie P, Wu J, Wang H, Zhou R, Sun L, Chen J, et al. Primary hepatic perivascular epithelioid cell tumours: imaging findings with histopathological correlation. Cancer Imaging 2019;19:32. 
  28. Shen HQ, Chen DF, Sun XH, Li X, Xu J, Hu XB, et al. MRI diagnosis of perivascular epithelioid cell tumour (PEComa) of the liver. Rom J Morphol Embryol 2013;54:643-647. 
  29. Maebayashi T, Abe K, Aizawa T, Sakaguchi M, Ishibashi N, Abe O, et al. Improving recognition of hepatic perivascular epithelioid cell tumour: case report and literature review. World J Gastroenterol 2015;21:5432-5441.  https://doi.org/10.3748/wjg.v21.i17.5432
  30. Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol 2010;41:1-15.  https://doi.org/10.1016/j.humpath.2009.05.011
  31. Lazar DC, Avram MF, Romosan I, Vacariu V, Goldis A, Cornianu M. Malignanthepatic vascular tumours in adults: characteristics, diagnostic difficulties and currentmanagement. World J Clin Oncol 2019;10:110-135.  https://doi.org/10.5306/wjco.v10.i3.110
  32. Yugawa K, Yoshizumi T, Mano Y, Kurihara T, Yoshiya S, Takeishi K, et al. Solitary fibrous tumour in the liver: case report and literature review. Surg Case Rep 2019;5:68. 
  33. Chan G, Horton PJ, Thyssen S, Lamarche M, Nahal A, Hill DJ, et al. Malignant transformation of a solitary fibrous tumour of the liver and intractable hypoglycemia. J Hepatobiliary Pancreat Surg 2007;14:595-599.  https://doi.org/10.1007/s00534-007-1210-0
  34. Bejarano-Gonzalez N, Garcia-Borobia FJ, Romaguera-Monzonis A, Garcia-Monforte N, Falco-Fages J, Bella-Cueto MR, et al. Solitary fibrous tumour of the liver. Case report and review of the literature. Rev Esp Enferm Dig 2015;107:633-639.  https://doi.org/10.17235/reed.2015.3676/2014
  35. Adams J, Lodge JP, Parker D. Liver transplantation for metastatic hemangiopericytoma associated withhypoglycemia. Transplantation 1999;67:488-489.  https://doi.org/10.1097/00007890-199902150-00027
  36. Miller WJ, Dodd GD 3rd, Federle MP, Baron RL. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 1992;159:53-57.  https://doi.org/10.2214/ajr.159.1.1302463
  37. Da Ines D, Petitcolin V, Joubert-Zakeyh J, Demeocq F, Garcier JM. Epithelioid hemangioendothelioma of the liver with metastatic coeliac lymph nodes in an 11-year-old boy. Pediatr Radiol 2010;40:1293-1296.  https://doi.org/10.1007/s00247-009-1532-y
  38. Ros PR, Erturk SM. Malignant Tumours of the Liver. In: Gore RM, Levine MS, eds. Textbook of Gastrointestinal Radiology. 5th ed. Elsevier Inc., 2021:788-818. 
  39. Lyburn ID, Torreggiani WC, Harris AC, Zwirewich CV, Buckley AR, Davis JE, et al. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol 2003;180:1359-1364.  https://doi.org/10.2214/ajr.180.5.1801359
  40. Lau K, Massad M, Pollak C, Rubin C, Yeh J, Wang J, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest 2011;140:1312-1318.  https://doi.org/10.1378/chest.11-0039
  41. Flucke U, Vogels RJ, de Saint Aubain Somerhausen N, Creytens DH, Riedl RG, van Gorp JM, et al. Epithelioid hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagn Pathol 2014;9:131. 
  42. Doyle LA, Fletcher CD, Hornick JL. Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics. Am J Surg Pathol 2016;40:94-102.  https://doi.org/10.1097/PAS.0000000000000511
  43. Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 2013;52:775-784.  https://doi.org/10.1002/gcc.22073
  44. Levy DW, Rindsberg S, Friedman AC, Fishman EK, Ros PR, Radecki PD, et al. Thorotrast-induced hepatosplenic neoplasia: CT identification. AJR Am J Roentgenol 1986;146:997-1004.  https://doi.org/10.2214/ajr.146.5.997
  45. Zheng YW, Zhang XW, Zhang JL, Hui ZZ, Du WJ, Li RM, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol 2014;29:906-911.  https://doi.org/10.1111/jgh.12506
  46. Worawattanakul S, Semelka RC, Kelekis NL, Woosley JT. Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy. Magn Reson Imaging 1997;15:613-617.  https://doi.org/10.1016/S0730-725X(96)00393-1
  47. Yasir S, Torbenson MS. Angiosarcoma of the liver: clinicopathologic features and morphologic patterns. Am J Surg Pathol 2019;43:581-590.  https://doi.org/10.1097/PAS.0000000000001228
  48. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006;107:2108-2121.  https://doi.org/10.1002/cncr.22225
  49. Li DB, Si XY, Wan T, Zhou YM. A pooled analysis of treatment and prognosis of hepatic angiosarcoma in adults. Hepatobiliary Pancreat Dis Int 2018;17:198-203.  https://doi.org/10.1016/j.hbpd.2018.04.005
  50. Omiyale AO, Carton J. Clinical and pathologic features of primary angiosarcoma of the kidney. Curr Urol Rep 2018;19:4. 
  51. Huang NC, Kuo YC, Chiang JC, Hung SY, Wang HM, Hung YM, et al. Hepatic angiosarcoma may have fair survival nowadays. Medicine (Baltimore) 2015;94:e816. 
  52. Goh IY, Mulholland P, Sokolova A, Liu C, Siriwardhane M. Hepatic small vessel neoplasm - a systematic review. Ann Med Surg (Lond) 2021;72:103004. 
  53. Gill RM, Buelow B, Mather C, Joseph NM, Alves V, Brunt EM, et al. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Hum Pathol 2016;54:143-151.  https://doi.org/10.1016/j.humpath.2016.03.018
  54. Lewis S, Aljarallah B, Trivedi A, Thung SN. Magnetic resonance imaging of a small vessel hepatic haemangioma in a cirrhotic patient with histopathologic correlation. Clin Imaging 2015;39:702-706.  https://doi.org/10.1016/j.clinimag.2015.02.007
  55. Rangaswamy B, Minervini M, Tublin M, Sholosh B, Dasyam AK. Imaging and pathologic findings of hepatic small vessel haemangioma. Curr Probl Diagn Radiol 2019;48:626-628.  https://doi.org/10.1067/j.cpradiol.2018.02.006
  56. Walcott-Sapp S, Tang E, Kakar S, Shen J, Hansen P. Resection of the largest reported hepatic small vessel neoplasm. Hum Pathol 2018;78:159-162.  https://doi.org/10.1016/j.humpath.2018.01.013
  57. Joseph NM, Brunt EM, Marginean C, Nalbantoglu I, Snover DC, Thung SN, et al. Frequent GNAQ and GNA14 mutations in hepatic small vessel neoplasm. Am J Surg Pathol 2018;42:1201-1207.  https://doi.org/10.1097/PAS.0000000000001110
  58. Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, et al. Diagnosis, management, and outcomes of 115 patients with hepatic haemangioma. J Am Coll Surg 2003;197:392-402.  https://doi.org/10.1016/S1072-7515(03)00420-4
  59. Brouwers MA, Peeters PM, de Jong KP, Haagsma EB, Klompmaker IJ, Bijleveld CM, et al. Surgical treatment of giant haemangioma of the liver. Br J Surg 1997;84:314-316.  https://doi.org/10.1046/j.1365-2168.1997.02534.x
  60. Christison-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, et al. Hepatic haemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007;42:62-67.  https://doi.org/10.1016/j.jpedsurg.2006.09.041
  61. Bajenaru N, Balaban V, Savulescu F, Campeanu I, Patrascu T. Hepatic hemangioma -review-. J Med Life 2015;8 Spec Issue(Spec Issue):4-11. 
  62. Jia K, Gao Z, Li M, Yu C. Interventional treatments for hepatic hemangioma: A state-of-the-art review. J Interv Med 2022;5:6-9.  https://doi.org/10.1016/j.jimed.2021.12.009
  63. Van Leer-Greenberg B, Kole A, Chawla S. Hepatic Kaposi sarcoma: A case report and review of the literature. World J Hepatol 2017;9:171- 179.  https://doi.org/10.4254/wjh.v9.i4.171
  64. Arora M, Goldberg EM. Kaposi sarcoma involving the gastrointestinal tract. Gastroenterol Hepatol (N Y) 2010;6:459-462. 
  65. Mulholland P, Goh IY, Sokolova A, Liu C, Siriwardhane M. Hepatic small vessel neoplasm case report: A surveillance conundrum. Int J Surg Case Rep 2021;81:105742. 
  66. Kumar A, Sharma B, Samant H. Liver Angiosarcoma [Internet]. StatPearls Publishing, 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538224/. 
  67. Chen N, Yu AJS, Jung J. Primary hepatic angiosarcoma: a brief review of the literature. EMJ Hepatol 2018;6:64-71.  https://doi.org/10.33590/emjhepatol/10314175
  68. Kou K, Chen YG, Zhou JP, Sun XD, Sun DW, Li SX, et al. Hepatic epithelioid hemangioendothelioma: Update on diagnosis and therapy. World J Clin Cases 2020;8:3978-3987.  https://doi.org/10.12998/wjcc.v8.i18.3978
  69. Virarkar M, Saleh M, Diab R, Taggart M, Bhargava P, Bhosale P. Hepatic hemangioendothelioma: an update. World J Gastrointest Oncol 2020;12:248-266. https://doi.org/10.4251/wjgo.v12.i3.248